Rapamycin Ameliorates Proteinuria and Restores Nephrin and Podocin Expression in Experimental Membranous Nephropathy

Rituximab in Idiopathic Membranous Nephropathy

(2012) P. Ruggenenti et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Pathogenesis of membranous nephropathy: recent advances and future challenges

(2012) Pierre Ronco et al.   Nature Reviews Nephrology

Rapamycin induced ultrastructural and molecular alterations in glomerular podocytes in healthy mice

(2012) Kostas Stylianou et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Rituximab-Induced Depletion of Anti-PLA2R Autoantibodies Predicts Response in Membranous Nephropathy

(2011) L. H. Beck et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Early-Childhood Membranous Nephropathy Due to Cationic Bovine Serum Albumin

(2011) Hanna Debiec et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antigen Identification in Membranous Nephropathy Moves toward Targeted Monitoring and New Therapy

(2010) P. Ronco et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Autoimmunity in Membranous Nephropathy Targets Aldose Reductase and SOD2

(2010) M. Prunotto et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Spontaneous Remission of Nephrotic Syndrome in Idiopathic Membranous Nephropathy

(2010) N. Polanco et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

The PI3K/Akt/mTOR pathway is activated in murine lupus nephritis and downregulated by rapamycin

(2010) Kostas Stylianou et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Rapamycin has dual opposing effects on proteinuric experimental nephropathies: is it a matter of podocyte damage?

(2009) J. Torras et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

M-Type Phospholipase A2Receptor as Target Antigen in Idiopathic Membranous Nephropathy

(2009) Laurence H. Beck et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mammalian Target of Rapamycin Inhibition Prevents Glomerular Hypertrophy in a Model of Renal Mass Reduction

(2009) Jordi Rovira et al.   TRANSPLANTATION

Podocyte foot process effacement as a diagnostic tool in focal segmental glomerulosclerosis

(2008) Jeroen K.J. Deegens et al.   KIDNEY INTERNATIONAL

Rapamycin prevents the development of nephritis in lupus-prone NZB/W F1 mice

(2008) SL Lui et al.   LUPUS

Rapamycin attenuates the severity of established nephritis in lupus-prone NZB/W F1 mice

(2008) S. L. Lui et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

The mTOR Inhibitor Everolimus Attenuates the Time Course of Chronic Anti-Thy1 Nephritis in the Rat

(2008) Sandra Wittmann et al.   NEPHRON EXPERIMENTAL NEPHROLOGY

Effects of Immunosuppressive Drugs On Purified Human B Cells: Evidence Supporting the Use of MMF and Rapamycin

(2008) Sebastiaan Heidt et al.   TRANSPLANTATION